There have been a couple of posts on TOMAC devices recently.
I've just dug out an email I wrote in June this year to the company making one such device - Noctrix Health. Here's Noctrix Health's reply..
"The FDA has recently allowed us to start marketing and distributing our wearable medical device that is intended to reduce symptoms of primary moderate-severe Restless Legs Syndrome and to improve sleep quality in adults refractory to medications.
With the FDA granting us the ability to start distributing our product, we are currently building up our inventory to support demand and will provide updates on the availability of the product to patients and physicians.
We expect to start a limited launch of product release ONLY in certain U.S. geographies later this summer. We are not allowed to sell in countries other than the U.S. currently. We greatly appreciate your patience as we continue to work to make our technology available to those that need it most. We have added you to our list of patients to stay in contact with as new developments arise and as our Noctrix product becomes more available."
**Here are the specific questions i asked Noctrix Health:
1. Does the TOMAC System treat Periodic Limb Movement Disorder?
We have only studied our device in treating RLS
2. Are there any plans to have the TOMAC System approved by the Australian Therapeutic Goods Administration (equivalent to the US FDA)?
Currently we are concentrating in the US. This may change as we grow and scale.
3. Is it possible to purchase a device privately? I'm in Australia.
We are only allowed to sell in the US currently. Do you ever travel to the US?
4. Is it possible to receive a copy of the outcome of the trial which resulted in FDA approval of the TOMAC System?
Thank you for your inquiry regarding our clinical trial data. The results of our randomized controlled trial, which was the basis of our FDA De Novo grant, are currently under review for publication in a journal. When the results are publicly available, we will share a link to the paper on our website. Until that time, the publication of our pilot trial results, which was the basis of our FDA Breakthrough Designation Grant, can be found here. You can also learn more about the mechanisms of action that govern our device in the publication found here. Please do not hesitate to contact us if you have any further questions about the studies or our device.